Showing of 7 results
Multiple Myeloma Patients at UH Seidman Cancer Center First in Ohio to Receive New CAR T-Cell Therapy
Patients also have access to promising clinical trial of vactosertib and pomalidomide - Innovations in Cancer | Summer 2021
Center offers dozens of clinical trials, including soon a rare all-human protein CAR T trial for patients with certain hematologic malignancies - Innovations in Cancer | Winter 2021
Investigational New Drug (IND) authorization is under way - Innovations in Cancer | Fall 2020
UH Seidman Cancer Center team can culture cells in just eight days - Innovations in Cancer | Winter 2020
UH Seidman Cancer Center Update | October 2019
2017 UH Annual Report to the Community and Report on Philanthropy Every day, the battle rages on at the microscopic level in our bodies. T cells deploy, seeking and destroying infected or abnormal cells that cause illness. Over the past decade,...
Hematology Update - Summer 2018 IT’S ALL ABOUT CELLS! Harnessing cells of the immune system to eradicate various types of cancer has been a strong focus of cancer research in our program over the past five years. Here we highlight two new cellular...